You are viewing a limited version of this profile. To access i3's full capabilities.
Hyalose
Save
Company logo (jpg or png)
Parent company

Short description

Developer of recombinant technologies for producing biomolecule, hyaluronic acid

Founded in 2001
Founded in

Company type Private Public ()
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Austin, TX Austin, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 11/23/2020

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
03/26/2019
Echelon Biosciences Echelon Biosciences
Echelon Biosciences was selected as the sole authorized distributor for Select-HA™ products from Hyalose.
View source    
Confirmed by Echelon Biosciences
Channel Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
12/09/2008 State of Oklahoma’s EDGE State of Oklahoma’s EDGE (1)
Post-money valuation of
Grant award to build a center for manufacturing hyaluronic acid (HA) and related glycosaminoglycans (GAG’s) products in Presbyterian Health Foundation’s Research Park in Oklahoma City.. The products will be utilized to formulate clinical diagnostic tools and companion therapies.
Grant $1,230,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font